Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer

Authors

  • Samantha Warren The Gray Institute of Radiation Oncology and Biology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, UK; Oxford Cancer Centre, Churchill Hospital, Oxford University Hospitals, Headington, Oxford, UK
  • Mike Partridge The Gray Institute of Radiation Oncology and Biology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, UK; Oxford Cancer Centre, Churchill Hospital, Oxford University Hospitals, Headington, Oxford, UK
  • Emmanouil Fokas The Gray Institute of Radiation Oncology and Biology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, UK;Oxford Cancer Centre, Churchill Hospital, Oxford University Hospitals, Headington, Oxford, UK
  • Cynthia L. Eccles The Gray Institute of Radiation Oncology and Biology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, UK; Oxford Cancer Centre, Churchill Hospital, Oxford University Hospitals, Headington, Oxford, UK
  • Thomas B. Brunner The Gray Institute of Radiation Oncology and Biology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford, UK; Oxford Cancer Centre, Churchill Hospital, Oxford University Hospitals, Headington, Oxford, UK

DOI:

https://doi.org/10.3109/0284186X.2013.813072

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2013-10-01

How to Cite

Warren, S., Partridge, M., Fokas, E., Eccles, C. L., & Brunner, T. B. (2013). Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer. Acta Oncologica, 52(7), 1573–1578. https://doi.org/10.3109/0284186X.2013.813072